Stay updated on CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Sign up to get notified when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.

Latest updates to the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page
- Check4 days agoChange DetectedThe study's recruitment status was updated to No longer looking for participants, reflecting the end of enrollment; a new page revision v3.6.0 was added and the previous revision v3.5.5 was removed.SummaryDifference0.3%

- Check11 days agoChange DetectedThe study history now shows Revision: v3.5.5, replacing the previous v3.5.4. This indicates a new revision entry was recorded in the history.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe history now includes a new Revision: v3.5.4 entry, replacing the previous v3.5.3. This update signals a refreshed page version in the record history for the study record.SummaryDifference0.1%

- Check40 days agoChange DetectedThe References section was removed from the study record view, removing bibliographic citations from this page.SummaryDifference0.1%

- Check54 days agoChange DetectedUpdated the page’s software/footer revision indicator from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the study record history.SummaryDifference0.1%

Stay in the know with updates to CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome
Enter your email address, and we'll notify you when there's something new on the CARDINAL Trial: Bardoxolone Methyl in Alport Syndrome page.